About: A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat. Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Multicenter,randomized,double-blind clinical trial of combination therapy with adalimumab + methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Multicenter,randomized,double-blind clinical trial of combination therapy with adalimumab + methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment (en) Multicentrické, randomiz., dvojitě zaslepené klinické hodnocení v kombinované terapii s adalimumabem plus methotrexátem oproti samotnému methotrexátu nebo adalimumabu u pacientů s časnou, agresivní revmatoidní artritidou bez předešlé methotrexátové léčby (cs)
Title	A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat. Multicentrické, randomiz., dvojitě zaslepené klinické hodnocení v kombinované terapii s adalimumabem plus methotrexátem oproti samotnému methotrexátu nebo adalimumabu u pacientů s časnou, agresivní revmatoidní artritidou bez předešlé methotrexátové léčby (cs) A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat. (en)
skos:prefLabel	A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat. Multicentrické, randomiz., dvojitě zaslepené klinické hodnocení v kombinované terapii s adalimumabem plus methotrexátem oproti samotnému methotrexátu nebo adalimumabu u pacientů s časnou, agresivní revmatoidní artritidou bez předešlé methotrexátové léčby (cs) A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat. (en)
skos:notation	RIV/00216208:11110/06:00009661!RIV08-MSM-11110___
http://linked.open.../vavai/riv/strany	26;37
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...iv/cisloPeriodika	1
http://linked.open...vai/riv/dodaniDat	2008
http://linked.open...aciTvurceVysledku	Pavelka, Karel
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Univerzita Karlova v Praze / 1. lékařská fakulta
http://linked.open...dnocenehoVysledku	463604
http://linked.open...ai/riv/idVysledku	RIV/00216208:11110/06:00009661
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	PREMIER; Study; multicenter; randomized; double-blind; clinical; trial; combination; therapy; adalimumab; methotrexate; versus; methotrexate; alone; adalimumab; alone; patients; early; aggressive; rheumatoid; arthritis; previo (en)
http://linked.open.../riv/klicoveSlovo	trial patients early adalimumab arthritis double-blind therapy versus rheumatoid alone clinical multicenter Study methotrexate combination randomized aggressive PREMIER previo
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[1464A2DAE62C]
http://linked.open...i/riv/nazevZdroje	Arthritis and Rheumatism
http://linked.open...in/vavai/riv/obor	FE
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	9 (xsd:int)
http://linked.open...UplatneniVysledku	2006
http://linked.open...v/svazekPeriodika	54
http://linked.open...iv/tvurceVysledku	Pavelka, Karel
issn	0004-3591
number of pages	12 (xsd:int)
http://localhost/t...ganizacniJednotka	11110
is http://linked.open...avai/riv/vysledek of	A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat. A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat.

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software